Latest Velcade Stories
THOUSAND OAKS, Calif., May 27, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present data from multiple Kyprolis(®) (carfilzomib) for Injection, BLINCYTO(®) (blinatumomab),
THOUSAND OAKS, Calif., May 13, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that data at the 51(st) Annual Meeting of the American Society of Clinical Oncology (ASCO) will showcase the
Ubiquitin system produces a protein that greatly restricts the development of cancerous tumors NEW YORK, April 17, 2015 /PRNewswire-USNewswire/ -- Dr.
Study Met Primary Endpoint of Progression-Free Survival THOUSAND OAKS, Calif.
Public Healthcare Systems in Brazil and Mexico Cover Targeted Therapies but with Indication-Specific Restrictions, According to Findings from Decision Resources Group BURLINGTON, Mass., June
This grant awarded to Northwest Natural Health Specialty Care Clinic marks the first time a global pharmaceutical company has contracted with an independent naturopathic clinic to investigate
Reportbuyer.com just published a new market research report:
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.